Ivan Milinković, born on July 2, 1981, in Belgrade, Serbia, is a father of two children. He graduated from the University of Belgrade Medical School in 2007 with an average grade of 9.71. He has been employed at the Clinic of Cardiology, Clinical Center of Serbia, since 2009. In 2011, he completed his specialized academic studies at the University of Belgrade Medical School, with a thesis titled “Assessment of the Risk of Complications in Patients with Primary Dilated Cardiomyopathy.” In 2019, he completed a Postgraduate Course in Heart Failure at the University of Zurich, and in 2022, he defended his doctoral dissertation on the topic “Influence of Gender and Age on the Quality of Treatment, Morbidity, and Mortality in Heart Failure” at the University of Belgrade Medical School. He is a specialist in internal medicine and a Clinical Assistant at the University of Belgrade Medical School.

Internationally, he has been a member of the Committee on Cardiomyopathies and Structural Heart Diseases of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) from 2018 to 2020. He has also been a member of the nucleus of the Heart Failure Specialist of Tomorrow (HoT) of HFA of ESC from 2018 to 2022. Additionally, he has been a member of the Working Group on Myocardial and Pericardial Disease of the European Society of Cardiology since 2011, the Heart Failure Association of the European Society of Cardiology since 2011, and the Cardiology Association of Serbia since 2010.

He has completed various courses, including the Diagnosis and Treatment of Pulmonary Hypertension at AKH, Vienna, in 2010, Right Heart Catheterization Course at Kerckhof Clinic, Ban Neuheim, in 2010, Treatment of Terminal Heart Failure Course in Bern, Switzerland, in 2012, and the School for Clinical Researchers at the Heart Failure Association of the ESC Clinical Trialist Summer School in Cape Sounio, Greece, in 2017. He holds a certificate for stress testing and ergospirometry.

He actively participated in the publication of the National Good Clinical Practice Guide for the Diagnosis and Treatment of Heart Failure, the translation of the Pocket Version of the European Recommendations for the Treatment of Acute and Chronic Heart Failure in 2016 and 2021, and the recommendations of the Heart Failure Association for the Treatment of Heart Failure with Preserved Ejection Fraction in 2022. He is the author of more than 40 publications, including 19 full-length original papers in journals with JCR listing. Nine papers have been published in top-level journals (M21), all in the M21a category. The cumulative impact factor of his publications is 222, with a total citation count of over 4600 and an H-index of 16. He has delivered more than 40 invited lectures at national and international congresses, including the Heart Failure Congress in 2019. He is a co-author of seven chapters in national and one in an international textbook in the field of cardiology. He serves as a reviewer for the ESC Heart Failure journal and participates in international projects such as Peptides for Life, focusing on the application of natriuretic peptides in acute heart failure, and the HFA Atlas dedicated to the epidemiology of heart failure in Europe.